Charlotte's Web Establishes Scientific Advisory Board to Enhance Medical Strategy
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 04 2025
0mins
Should l Buy ?
Source: NASDAQ.COM
Formation of Scientific Advisory Board: Charlotte's Web Holdings, Inc. has established a Scientific Advisory Board to enhance its medical strategy and promote science-backed innovation, focusing on patient-centered solutions starting September 2025.
Research and Development Initiatives: The board, led by Dr. Marcel Bonn-Miller, will oversee research, clinical initiatives, and product development, including the advancement of AJA001, a CBD extract cleared for Phase 2 trials for treating irritability in autism spectrum disorder.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
